Image_3_Mechanisms of FH Protection Against Neovascular AMD.TIFF (378.12 kB)
Download file

Image_3_Mechanisms of FH Protection Against Neovascular AMD.TIFF

Download (378.12 kB)
posted on 03.04.2020, 11:15 by Céline Borras, Kimberley Delaunay, Yousri Slaoui, Toufik Abache, Sylvie Jorieux, Marie-Christine Naud, Mohamed El Sanharawi, Emmanuelle Gelize, Patricia Lassiaz, Na An, Laura Kowalczuk, Cédric Ayassami, Alexandre Moulin, Francine Behar-Cohen, Frédéric Mascarelli, Virginie Dinet

A common allele (402H) of the complement factor H (FH) gene is the major risk factor for age-related macular degeneration (AMD), the leading cause of blindness in the elderly population. Development and progression of AMD involves vascular and inflammatory components partly by deregulation of the alternative pathway of the complement system (AP). The loss of central vision results from atrophy and/or from abnormal neovascularization arising from the choroid. The functional link between FH, the main inhibitor of AP, and choroidal neovascularization (CNV) in AMD remains unclear. In a murine model of CNV used as a model for neovascular AMD (nAMD), intraocular human recombinant FH (recFH) reduced CNV as efficiently as currently used anti-VEGF (vascular endothelial growth factor) antibody, decreasing deposition of C3 cleavage fragments, membrane attack complex (MAC), and microglia/macrophage recruitment markers in the CNV lesion site. In sharp contrast, recFH carrying the H402 risk variant had no effect on CNV indicating a causal link to disease etiology. Only the recFH NTal region (recFH1-7), containing the CCPs1-4 C3-convertase inhibition domains and the CCP7 binding domain, exerted all differential biological effects. The CTal region (recFH7-20) containing the CCP7 and CCPs19-20 binding domains was antiangiogenic but did not reduce the microglia/macrophage recruitment. The antiangiogenic effect of both recFH1-20 and recFH-CCP7-20 resulted from thrombospondin-1 (TSP-1) upregulation independently of the C3 cleavage fragments generation. This study provides insight on the mechanistic role of FH in nAMD and invites to reconsider its therapeutic potential.